Calaspargase Pegol-mknl

 (kal-AS-par-jays PEH-gol)

This page contains brief information about calaspargase pegol-mknl and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

US Brand Name(s)
FDA Approved

FDA label information for this drug is available at Drugs@FDA

Use in Cancer

Calaspargase pegol-mknl is approved to treat:

Calaspargase pegol-mknl is also being studied in the treatment of other types of cancer.

More About Calaspargase Pegol-mknl

Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.

Clinical Trials Accepting Patients

Find Clinical Trials for Calaspargase Pegol-mknl - Check for trials from NCI's list of cancer clinical trials now accepting patients.

  • Posted: January 25, 2019